Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer

Breast cancer continues to be the most diagnosed cancer among women worldwide. Neoadjuvant chemotherapy is the standard of care for breast cancer patients with locally advanced disease and patients with poor pathological features, such as triple-negative (TN) or human epidermal growth factor recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Razeq, Hikmat, Khalil, Hanan, Assi, Hazem I., Dargham, Tarek Bou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406771/
https://www.ncbi.nlm.nih.gov/pubmed/36005196
http://dx.doi.org/10.3390/curroncol29080458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406771/
https://www.ncbi.nlm.nih.gov/pubmed/36005196
http://dx.doi.org/10.3390/curroncol29080458

Ejemplares similares